guanfacine has been researched along with Intellectual Disability in 3 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Guanfacine was well tolerated, and did not lead to significant changes in blood pressure or heart rate." | 1.32 | Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. ( Kem, DL; McDougle, CJ; Posey, DJ; Puntney, JI; Sasher, TM, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Joshi, G | 1 |
| Wilens, T | 1 |
| Firmin, ES | 1 |
| Hoskova, B | 1 |
| Biederman, J | 1 |
| Boreman, CD | 1 |
| Arnold, LE | 1 |
| Posey, DJ | 1 |
| Puntney, JI | 1 |
| Sasher, TM | 1 |
| Kem, DL | 1 |
| McDougle, CJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-Center, Open Label, Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder[NCT03337646] | Phase 4 | 48 participants (Actual) | Interventional | 2018-09-26 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for guanfacine and Intellectual Disability
| Article | Year |
|---|---|
Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; | 2021 |
2 other studies available for guanfacine and Intellectual Disability
| Article | Year |
|---|---|
Hallucinations associated with initiation of guanfacine.
Topics: Aggression; Child; Guanfacine; Hallucinations; Humans; Intellectual Disability; Male; Sympatholytics | 2003 |
Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases.
Topics: Adolescent; Adrenergic alpha-Agonists; Aging; Asperger Syndrome; Attention Deficit Disorder with Hyp | 2004 |